During the past decade, OnkoNet Marburg GmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OnkoNet Marburg GmbH" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Takeda" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "Dominik Paul Modest" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OnkoNet Marburg GmbH" #1 collaborator was "German Research Foundation" with 1 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "OnkoNet Marburg GmbH" are "Non-Hodgkin's Lymphoma" (2 trials), "Breast Neoplasms" (1 trials), "Chronic Graft Versus Host Disease" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "OnkoNet Marburg GmbH" in a lesser frequency.

Most popular intervention types in "OnkoNet Marburg GmbH" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Rituximab" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Atezolizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "OnkoNet Marburg GmbH" are 11 trials for "All" genders.

Currently, there are NaN active trials in "OnkoNet Marburg GmbH". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in OnkoNet Marburg GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in OnkoNet Marburg GmbH, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".